Enanta Pharma (ENTA) Tops Q2 EPS by 10c, Misses on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 10.71 -0.44 (3.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.15 | 52 Week High | $34.49 | |||
| Open | $11.08 | 52 Week Low | $20.39 | |||
| Day High | $11.10 | P/E | N/A | |||
| Day Low | $10.69 | EPS | $-3.18 | |||
| Volume | 202,341 | |||||
